s.stavrianos
TL2 Member · Winnipeg, CA
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 21 March 2025 · last posted 2d
86 posts, newest first. Showing up to 150.
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #24 · Compounds › Retatrutide · 26 Jul 2026 · 5 likes Post #23 is the version of this I will quote in future. One addition. Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious…
-
[2026 update] Documenting an adverse event properly Replied, post #21 · Safety › Adverse events · 25 Jul 2026 · 28 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #117 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 11 likes The practical version of CJC-1295 is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Forced degradation studies: designing one that is informative Replied, post #96 · Analytics › Method validation · 11 Jul 2026 · 0 likes Nobody has said the unglamorous part of forced degradation studies yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Follow-up: Sleep quality changes during weight loss Replied, post #66 · Wellbeing › Sleep · 10 Jul 2026 · 0 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Revisiting: What pooling buys you and what it destroys Replied, post #75 · Evidence › Meta-analyses · 1 Jul 2026 · 24 likes Reframing pooling buys slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #77 · Safety › Contraindications · 17 Jun 2026 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Allergy to the specific compound: true allergy is rare but possible. Any prior…
-
Second pass at: Programming during a large energy deficit Replied, post #30 · Nutrition & Training › Resistance training · 16 Jun 2026 · 26 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Why this subcategory is stricter about sourcing than most Replied, post #42 · Compounds › Secretagogues & GH axis · 13 Jun 2026 · 2 likes Where I part company with post #40, and it is a narrow parting. Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Started this topic · Sourcing › Independent verification · 3 Jun 2026 · 38 likes On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion. Structured report rather than…
-
GLP-1 receptor distribution: central and peripheral Replied, post #58 · Pharmacology › Receptor biology · 28 May 2026 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #77 · Data & Tools › Calculators · 23 May 2026 · 3 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #58 · Compounds › Repair & healing peptides · 22 May 2026 · 17 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Where I would push back on the Stability of BPC-157 consensus is the confidence,…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #47 · Practice › Interactions · 20 May 2026 · 12 likes The thing about widely repeated interaction claim that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not…
-
Official shortage notices and what they authorise Replied, post #34 · Access › Shortages · 5 May 2026 · 0 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. Reading this official shortage notices thread as someone who came in with a fixed…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #123 · Analytics › Mass spectrometry · 28 Apr 2026 · 21 likes The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher charge states. Working it through once makes the reported…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #54 · Practice › Administration · 20 Apr 2026 · 19 likes Post #50 describes the usual case. This is about the unusual one. Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in…
-
Revisiting: Absolute versus relative contraindications Replied, post #68 · Safety › Contraindications · 17 Apr 2026 · 0 likes Picking up post #66: that is the part I would want checked first. Small correction to my own earlier position on Absolute versus relative contraindications. I had the…
-
Adolescents: a distinct evidence base — one year on Replied, post #87 · Clinical › Special populations · 16 Apr 2026 · 2 likes The arithmetic in post #84 is right; the assumption feeding it is the part to check. Adolescents: a distinct evidence base exists. The compounds are not approved for…
-
Spike-and-recover accuracy for a peptide assay Replied, post #112 · Analytics › Method validation · 10 Apr 2026 · 6 likes Small methodological point on spike-and-recover accuracy: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #60 · Clinical › Bloodwork · 6 Mar 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Realistic expectations for strength while losing weight quickly Replied, post #68 · Nutrition & Training › Resistance training · 5 Mar 2026 · 9 likes Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume, in that order. If the premise is wrong, everything after it…
-
Follow-up: Search filters: what is missing Replied, post #38 · Meta › Site feedback · 21 Feb 2026 · 28 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment. The uncertainty is in the…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #3 · Evidence › Journal club · 18 Feb 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #71 · Analytics › Mass spectrometry · 14 Feb 2026 · 2 likes Taking post #68 at face value and following it one step further. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #57 · Documentation › Doc review · 5 Feb 2026 · 10 likes I would rather this thread reach "we do not know" about evidence digest than reach a confident answer that nobody can support when asked.
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #29 · Compounds › Semaglutide · 3 Feb 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
EU-wide position versus national implementation — what changed since Replied, post #15 · Regional › European Union · 1 Feb 2026 · 2 likes The centralised authorisation covers the union and national access decisions do not. That distinction accounts for most of the apparent contradictions in this…
-
Trifluoroacetate content and its consequences Replied, post #62 · Analytics › Impurities & related substances · 1 Feb 2026 · 19 likes Sensible. I would want the same detail before I acted on it either.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #122 · Analytics › Home & field testing · 31 Jan 2026 · 0 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. Take it…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #11 · Compounds › Secretagogues & GH axis · 15 Jan 2026 · 11 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #18 · Practice › Storage & stability · 7 Jan 2026 · 8 likes Picking up post #15: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #2 · Sourcing › Payments · 6 Dec 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
MHRA statements, read directly Replied, post #39 · Regional › UK & Ireland · 28 Nov 2025 · 15 likes This follows post #36 rather than contradicting it. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #38 · Compounds › Semaglutide · 26 Nov 2025 · 31 likes Coming back to post #36, because the follow-up matters more than the original answer. On the "does it stop working" question: tolerance in the pharmacological sense is…
-
[2026 update] Long-time reader, first-time poster Replied, post #22 · Lounge › Introductions · 2 Nov 2025 · 0 likes An honest declaration on Long-time reader: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #13 · Evidence › Journal club · 29 Oct 2025 · 1 like Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
How the published trials escalated, tabulated side by side — does this still hold? Replied, post #3 · Practice › Dosing & titration · 28 Oct 2025 · 30 likes Narrowing post #2, because the general version has more than one answer. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #38 · Wellbeing › Mental health · 16 Oct 2025 · 26 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #38 · Start Here › Welcome · 15 Oct 2025 · 0 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
New subcategory: rationale and scope Replied, post #9 · Meta › Announcements · 12 Oct 2025 · 3 likes Post #6 is the version of this I will quote in future. One addition. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available…
-
Airline travel with a temperature-sensitive injectable Replied, post #5 · Devices › Cold chain · 30 Sep 2025 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on airline travel, because it is the sort of subject where it matters.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #55 · Analytics › HPLC & UHPLC · 28 Sep 2025 · 11 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #115 · Compounds › Retatrutide · 22 Sep 2025 · 0 likes Two people in this thread mean different things by Triple agonism and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Tracking that stops updating and then resumes — the long version Replied, post #13 · Sourcing › Logistics · 9 Sep 2025 · 6 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #57 · Evidence › Journal club · 18 Aug 2025 · 15 likes Everything in post #53 holds. The case it does not cover is the one I have. Reading order that works for these sessions: registry entry, methods, baseline table,…
-
Are there stupid questions here? A staff answer, at length Replied, post #81 · Start Here › Welcome · 17 Aug 2025 · 26 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Thyroid function tests during substantial weight change Replied, post #29 · Clinical › Bloodwork · 13 Aug 2025 · 25 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. I have changed my mind on this once…
-
Are there stupid questions here? A staff answer, at length Replied, post #64 · Start Here › Welcome · 12 Aug 2025 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #75 · Access › Insurance & coverage · 10 Aug 2025 · 12 likes The question underneath Reading a denial letter is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #94 · Compounds › Repair & healing peptides · 7 Aug 2025 · 0 likes Worth separating two things that post #92 runs together. An honest declaration on TB-500 and thymosin beta-4: I have a prior here and it is strong enough that you…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #18 · Evidence › Journal club · 2 Jul 2025 · 0 likes I would put moderate confidence on the mainstream reading of indirect comparison and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Reading an MS report that only gives you a single number Replied, post #113 · Analytics › Mass spectrometry · 20 Jun 2025 · 6 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Coming back to: When "no data" is the complete and final answer Replied, post #13 · Compounds › Other compounds · 14 Jun 2025 · 12 likes Storage guidance for the less common material is usually copied from the incretin guidance and may not apply. Where the supplier has its own stability statement, that…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #49 · Evidence › Trials · 10 Jun 2025 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Pre-registering a personal experiment, seriously Replied, post #4 · Research Methods › N-of-1 designs · 25 May 2025 · 0 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
-
Pregnancy as an absolute contraindication Replied, post #26 · Safety › Contraindications · 17 May 2025 · 15 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. Somebody's condition being on a list does not settle the decision, and somebody's…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #25 · Devices › Cold chain · 8 May 2025 · 22 likes Airline travel has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #64 · Compounds › Secretagogues & GH axis · 4 May 2025 · 0 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. Injection-site reactions are reported more often in this family…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #29 · Sourcing › Independent verification · 30 Apr 2025 · 14 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Genuinely open to being wrong about this one.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #81 · Compounds › Semaglutide · 17 Apr 2025 · 15 likes Post #78 is right about the mechanism and I think understates the practical bit. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #19 · Start Here › Welcome · 19 Mar 2025 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #136 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #114 · Compounds › Other compounds · 14 Mar 2025 · 1 like Adding the measurement that post #111 says would settle it. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
-
Scheduled maintenance and what will be unavailable Replied, post #72 · Meta › Announcements · 14 Mar 2025 · 1 like Everything in post #70 holds. The case it does not cover is the one I have. Scheduled maintenance looks different depending on whether you are reading the primary…
-
Transit times by route, from a logged dataset — the long version Replied, post #67 · Sourcing › Logistics · 6 Mar 2025 · 7 likes Post #66 answers the question as asked. The question underneath it is different. Something worth flagging about Transit times: the strongest-sounding claims in this…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #33 · Sourcing › Regulatory · 28 Feb 2025 · 16 likes Pharmaceutical compounding rules has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #102 · Data & Tools › Calculators · 23 Feb 2025 · 26 likes Post #100 describes the usual case. This is about the unusual one. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Adjudicated events and why the definition matters — the long version Replied, post #16 · Evidence › Trials · 19 Feb 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Second pass at: Regression to the mean in progress reports Replied, post #56 · Research Methods › Statistics · 15 Feb 2025 · 0 likes Post #52 and I disagree about the size of the effect, not about the direction. One caution on Regression: everything above assumes the underlying documentation is what…
-
Follow-up: What other technical communities get right that we do not Replied, post #17 · Lounge › Off topic · 14 Feb 2025 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #32 · Evidence › Meta-analyses · 11 Feb 2025 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Protein density versus volume when you cannot eat much Replied, post #81 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 0 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #112 · Evidence › Journal club · 1 Feb 2025 · 17 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Checking someone else's arithmetic: a worked example thread Replied, post #18 · Practice › Reconstitution · 30 Jan 2025 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #71 · Data & Tools › Calculators · 30 Jan 2025 · 9 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Recovery when intake is low: what to cut first Replied, post #41 · Nutrition & Training › Resistance training · 12 Jan 2025 · 0 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum. It cost…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #23 · Documentation › Doc review · 9 Jan 2025 · 7 likes A document that repeats a paragraph already maintained elsewhere should link instead, unless the reader would be mid-task and unable to follow a link. Anyone with a…
-
A page that has drifted out of date and needs a maintainer Replied, post #32 · Documentation › Wiki requests · 24 Nov 2024 · 7 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. Somebody will have a better source than mine, and I hope…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #16 · Practice › Side effects · 21 Nov 2024 · 29 likes Worth separating two things that post #12 runs together. Nobody has said the unglamorous part of injection-site reactions yet, so: most of the variation is explained by…
-
EMA product information as a primary source — does this still hold? Replied, post #140 · Regional › European Union · 18 Nov 2024 · 22 likes Confirming post #137 from a second method, which matters more than confirming it from a second person. EMA is the regulator with national implementation. Licensed…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #22 · Sourcing › Independent verification · 6 Nov 2024 · 8 likes Taking post #21 at face value and following it one step further. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
Blind submission and why it changes minds Replied, post #90 · Sourcing › Independent verification · 17 Oct 2024 · 0 likes The arithmetic in post #89 is right; the assumption feeding it is the part to check. Two questions I would want answered before drawing anything from the blind…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #22 · Compounds › Oral incretins · 19 Sep 2024 · 11 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Why a preprint's supplementary material is often the best part Replied, post #18 · Evidence › Preprints · 10 Sep 2024 · 0 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. Reading a preprint properly means doing some of the reviewer's job: methods first,…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #12 · Sourcing › Red flags · 26 Jul 2024 · 4 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. Reading it back, the second half matters…